Sir Gregory P. Winter
Who was Sir Gregory P. Winter?
Nobel laureate: Nobel Prize in Chemistry (2018)
Biographical data adapted from Wikipedia’s article on Sir Gregory P. Winter (CC BY-SA 4.0).
Biography
Sir Gregory Paul Winter, born on April 14, 1951, in Leicester, England, is a well-respected British molecular biologist. His pioneering work has changed how monoclonal antibodies are used in treatments, gaining him international fame and the 2018 Nobel Prize in Chemistry. Winter's career has largely been tied to Cambridge, where he did his most important work at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering.
Winter's biggest impact on science is his development of techniques to humanize antibodies for medical use. Before his innovations, medical treatments often used antibodies from mice, but these caused problems when used in humans. The human immune system saw these mouse-derived antibodies as foreign and attacked them, which greatly reduced their effectiveness. Winter solved this problem by creating methods to modify these antibodies so they would work with human biology.
In 1986, Winter first developed techniques to humanize antibodies. He then took it a step further by inventing ways to fully humanize antibodies using phage display technology. This allowed the creation of fully human antibodies that could be used in treatments without causing harmful immune reactions. His breakthroughs opened up new treatment options for various diseases, like cancer and autoimmune disorders, and formed the basis for many current antibody-based therapies.
Throughout his career, Winter has held many important roles. He was Deputy Director of the Laboratory of Molecular Biology at the Medical Research Council from 2006 to 2011 and served as Director from 2007 to 2008. From 1994 to 2006, he led the Division of Protein and Nucleic Acids Chemistry, and he was Deputy Director of the MRC Centre for Protein Engineering from 1990 until it closed in 2010. In 2012, he became Master of Trinity College, Cambridge, a role he held until 2019. His work has been celebrated with many awards, including the Nobel Prize in Chemistry in 2018, which he shared with George Smith and Frances Arnold for their work on the directed evolution of enzymes and antibodies.
Before Fame
Winter studied at the Royal Grammar School and then went on to Trinity College, Cambridge, where he focused on molecular biology. He started his career when molecular biology was rapidly advancing, especially in terms of understanding protein structure and function.
The 1970s and 1980s were a time of big changes in biotechnology and molecular medicine. During these years, scientists started figuring out how to modify biological systems for medical treatments. The mid-1970s saw the development of monoclonal antibody technology, which opened up new possibilities for treating diseases, though there were still major challenges in making these treatments safe and effective for people. It was in this environment of scientific progress and technical hurdles that Winter began his work in antibody engineering.
Key Achievements
- Developed the first techniques to humanize monoclonal antibodies for therapeutic use in 1986
- Invented methods to create fully human antibodies using phage display technology
- Awarded the 2018 Nobel Prize in Chemistry for contributions to antibody engineering
- Served as Master of Trinity College, Cambridge from 2012 to 2019
- Led key divisions at MRC Laboratory of Molecular Biology and Centre for Protein Engineering for over two decades
Did You Know?
- 01.He was appointed Master of Trinity College, Cambridge in 2012, the same college where he had been a student and later became a Fellow
- 02.Winter's antibody humanization techniques have been used to develop over 30 FDA-approved therapeutic antibodies
- 03.He received the Commander of the Order of the British Empire in 1996, eight years before being knighted as a Knight Bachelor in 2004
- 04.The MRC Centre for Protein Engineering, where much of his groundbreaking work took place, operated for 20 years before closing in 2010
- 05.His Nobel Prize was awarded for work spanning over three decades, from his initial humanization techniques in 1986 to fully human antibodies using phage display
Awards & Honors
| Award | Year | Details |
|---|---|---|
| Nobel Prize in Chemistry | 2018 | for the phage display of peptides and antibodies |
| Commander of the Order of the British Empire | 1996 | — |
| Royal Medal | 2011 | — |
| Princess of Asturias Award for Technical and Scientific Research | 2012 | — |
| Canada Gairdner International Award | 2013 | — |
| Emil-von-Behring-Prize | 1990 | — |
| William B. Coley Award | 1999 | — |
| Wilhelm Exner Medal | 2015 | — |
| Scheele Award | 1994 | — |
| King Faisal International Prize in Medicine | 1995 | — |
| Knight Bachelor | 2004 | — |
| Colworth Medal | 1986 | — |
| Fellow of the Australian Academy of Technology and Engineering | — | — |
| Fellow of the Academy of Medical Sciences | — | — |
| Baly Medal | 2005 | — |
| Prince Mahidol Award | 2016 | — |
| honorary doctorate of the University of Natural Resources and Life Sciences, Vienna | 2020 | — |
| Louis-Jeantet Prize for Medicine | 1989 | — |
| Gabbay Award | 2002 | — |
| Honorary member of the British Biophysical Society | — | — |
| honorary doctorate from University of Nantes | 2001 | — |
| Copley Medal | 2025 | — |